ASSOCIATED PARTNER
Luxembourg Institute of Health
The Luxembourg Institute of Health is a public biomedical research organisation. Striving for excellence, its researchers, by their creativity, enthusiasm and commitment, generate knowledge on disease mechanisms and contribute to the development of new diagnostics, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens. The activities of the Luxembourg Institute of Health are developed within the following research topics: Oncology, Infection and Immunity, Population Health.
At the forefront of biomedical sciences, the Luxembourg Institute of Health is deeply involved in implementing national and international research programs in personalized medicine. It acts as a catalyst for promoting research collaborations with healthcare providers, hospitals and other public and private biomedical organisations. To create economic and societal value, it purposes the transfer of its scientific discoveries and technological developments. As the first supplier of public health information in Luxembourg, it also enables public authorities to make decisions based on scientific data and to communicate validated data to international institutions.
About the services
LIH has extensive experience working with health datasets from the national cohorts, collections and clinical studies it runs as well as the public health registries it manages on behalf of the MSSS. We bring expertise in standardizing health data (OMOP CDM, HealthDCAT-AP, openEHR) and ensuring that secondary use of health data is GDPR and ethically compliant. LIH commits to active participation in the Factory's working groups.
LIH operates as both a data provider and a technical use-case developer. Contributions include:
- Data Provision: providing metadata of the data sets that fall under the DGA criteria to feed the national data catalog.
- Use-Case Testing: Deploying applied clinical research projects, such as federated health data integration and AI-driven precision oncology tools, to test the platform infrastructure.